New brief therapy aims to curb drinking in opioid patients

NCT ID NCT07342504

First seen Jan 19, 2026 · Last updated May 14, 2026 · Updated 15 times

Summary

This study tests a short, tailored alcohol intervention for 60 adults who are taking buprenorphine for opioid use and also drink alcohol. The program aims to reduce drinking and improve treatment satisfaction. Researchers will check if the approach is practical and liked by participants before planning a larger trial.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALCOHOL USE DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • The University of Notre Dame

    RECRUITING

    Notre Dame, Indiana, 46556, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.